Page last updated: 2024-08-16

tibolone and trelstar

tibolone has been researched along with trelstar in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Compston, JE; Croucher, PI; Garrahan, NJ; Lindsay, PC; Shaw, RW; Yamaguchi, K1
Bennink, HJ; Kicovic, P; Lindsay, PC; Shaw, RW1
Bell, KL; Compston, JE; Garrahan, N; Lindsay, PC; Loveridge, N; Lunt, M; Reeve, J1
Bell, KL; Boyde, A; Compston, JE; Jones, SJ; Loveridge, N; Noble, BS; Reeve, J1
Göçmen, A; Kara, IH; Karaca, M1
Balasch, J; Camus, A; Castelo-Branco, C; Martínez de Osaba, MJ; Mercadal, S; Nomdedeu, B1
Lashen, H; Roberts, AL1
Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL1
Alshehre, SM; Duffy, S; Jones, G; Ledger, WL; Metwally, M1

Trials

6 trial(s) available for tibolone and trelstar

ArticleYear
The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis.
    Bone, 1995, Volume: 16, Issue:2

    Topics: Adult; Anabolic Agents; Biopsy; Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Norpregnenes; Osteoporosis, Postmenopausal; Premenopause; Triptorelin Pamoate

1995
The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
    Fertility and sterility, 1996, Volume: 65, Issue:2

    Topics: Adult; Anabolic Agents; Bone Density; Double-Blind Method; Drug Interactions; Endometriosis; Female; Humans; Leiomyoma; Luteolytic Agents; Norpregnenes; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms

1996
The effects of add-back therapy with tibolone on myoma uteri.
    Clinical and experimental obstetrics & gynecology, 2002, Volume: 29, Issue:3

    Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Prospective Studies; Treatment Outcome; Triptorelin Pamoate; Ultrasonography; Uterine Neoplasms

2002
Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
    Fertility and sterility, 2007, Volume: 87, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Norpregnenes; Ovary; Prednisone; Primary Ovarian Insufficiency; Procarbazine; Triptorelin Pamoate; Vinblastine; Vincristine

2007
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
    Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3

    Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins

2013
A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.
    Reproductive biology and endocrinology : RB&E, 2020, Apr-14, Volume: 18, Issue:1

    Topics: Adult; Bone Density; Chronic Pain; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Norpregnenes; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Time Factors; Treatment Outcome; Triptorelin Pamoate

2020

Other Studies

3 other study(ies) available for tibolone and trelstar

ArticleYear
Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:8

    Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers; Biopsy; Bone Density; Bone Remodeling; Drug Therapy, Combination; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Isoenzymes; Norpregnenes; Osteoclasts; Osteoporosis, Postmenopausal; Software; Tartrate-Resistant Acid Phosphatase; Triptorelin Pamoate

1997
Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging.
    Bone, 1998, Volume: 22, Issue:3

    Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy; Bone Density; Calcification, Physiologic; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Goserelin; Humans; Ilium; Microscopy, Electron, Scanning; Norpregnenes; Triptorelin Pamoate

1998
Tibolone as a hormone replacement in women with endometriosis after bilateral oophorectomy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2010, Volume: 111, Issue:2

    Topics: Abdomen; Adult; Chest Pain; Drainage; Endometriosis; Female; Hormone Replacement Therapy; Humans; Norpregnenes; Ovariectomy; Pelvis; Pleural Diseases; Radiography; Treatment Outcome; Triptorelin Pamoate; Ultrasonography

2010